{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:25:09Z","timestamp":1793053509660,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.maturitas.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T01:14:28Z","timestamp":1602810868000},"page":"118-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Type 2 diabetes management in people aged over seventy-five years: targets and treatment strategies"],"prefix":"10.1016","volume":"143","author":[{"given":"Theocharis","family":"Koufakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grammatiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Kotsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2020.10.005_bib0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0010","series-title":"National diabetes statistics report, 2017. Estimates of diabetes and its burden in the United States","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0015","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"China National Diabetes and Metabolic Disorders Study Group, Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0020","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00125-018-4547-9","article-title":"Diabetes in the Older Patient: Heterogeneity Requires Individualisation of Therapeutic Strategies","volume":"61","author":"Schernthaner","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0025","first-page":"38","article-title":"Diabetes in the Elderly","volume":"16","author":"Mordarska","year":"2017","journal-title":"Prz. Menopauzalny"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4239\/wjd.v8.i6.278","article-title":"Treatment of Type 2 Diabetes Mellitus in the Elderly","volume":"8","author":"Yakary\u0131lmaz","year":"2017","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2337\/dc16-1732","article-title":"The pathophysiology of hyperglycemia in older adults: clinical considerations","volume":"40","author":"Lee","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.metabol.2018.09.005","article-title":"The Epidemiology of Obesity","volume":"92","author":"Chooi","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/er.2016-1146","article-title":"Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications","volume":"38","author":"Mauvais-Jarvis","year":"2017","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2337\/dc11-1360","article-title":"Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988-2008","volume":"35","author":"Li","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0055","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.2337\/dc12-1801","article-title":"Diabetes in Older Adults","volume":"35","author":"Kirkman","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2337\/dc17-1437","article-title":"SFD\/SFGG Intergroup, Cardiovascular Complications Over 5 Years and Their Association With Survival in the GERODIAB Cohort of Elderly French Patients With Type 2 Diabetes","volume":"41","author":"Bauduceau","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0065","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/427690","article-title":"Serious infections in elderly patients with diabetes mellitus","volume":"40","author":"Rajagopalan","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0070","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.2337\/dc12-2197","article-title":"Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications","volume":"36","author":"Caughey","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0075","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archinternmed.2010.539","article-title":"Frequent Hypoglycemia Among Elderly Patients With Poor Glycemic Control","volume":"171","author":"Munshi","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.14336\/AD.2014.0330","article-title":"Hypoglycemia in older people - a less well recognized risk factor for frailty","volume":"10","author":"Abdelhafiz","year":"2015","journal-title":"Aging Dis"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0085","doi-asserted-by":"crossref","first-page":"e3013","DOI":"10.1002\/dmrr.3013","article-title":"The Impact of Cognitive Impairment in Dementia on Self-Care Domains in Diabetes: A Systematic Search and Narrative Review","volume":"34","author":"Santos","year":"2018","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"2020","key":"10.1016\/j.maturitas.2020.10.005_bib0090","first-page":"487","article-title":"Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"43","author":"Buse","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/dci16-0042","article-title":"Hemoglobin A 1c and Mortality in Older Adults With and Without Diabetes: Results From the National Health and Nutrition Examination Surveys (1988-2011)","volume":"40","author":"Palta","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0100","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/jgs.14215","article-title":"Mortality in individuals aged 80 and older with type 2 diabetes mellitus in relation to glycosylated hemoglobin, blood pressure, and total cholesterol","volume":"64","author":"Hamada","year":"2016","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0105","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Action to Control Cardiovascular Risk in Diabetes Study Group","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0110","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jamainternmed.2014.7345","article-title":"Potential Overtreatment of Diabetes Mellitus in Older Adults With Tight Glycemic Control","volume":"175","author":"Lipska","year":"2015","journal-title":"JAMA Intern. Med"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/dc14-0599","article-title":"Tight Glycemic Control and Use of Hypoglycemic Medications in Older Veterans With Type 2 Diabetes and Comorbid Dementia","volume":"38","author":"Thorpe","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0120","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12877-020-01780-9","article-title":"Poor health status, inappropriate glucose-lowering therapy and high one-year mortality in geriatric patients with type 2 diabetes","volume":"20","author":"Christiaens","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4158\/CS-2019-0472","article-title":"CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY","volume":"26","author":"Garber","year":"2020","journal-title":"Endocr. Pract"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0130","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.2337\/dc20-S006","article-title":"6. Glycemic Targets: Standards of Medical Care in Diabetes\u20142020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0140","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamainternmed.2016.2288","article-title":"Simplification of Insulin Regimen in Older Adults and Risk of Hypoglycemia","volume":"176","author":"Munshi","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0145","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"HYVET Study Group, Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0150","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1186\/s12877-017-0574-5","article-title":"Efficacy and Safety of Metformin in the Management of Type 2 Diabetes Mellitus in Older Adults: A Systematic Review for the Development of Recommendations to Reduce Potentially Inappropriate Prescribing","volume":"17","author":"Schlender","year":"2017","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207947","article-title":"Metformin Induces Significant Reduction of Body Weight, Total Cholesterol and LDL Levels in the Elderly - A Meta-Analysis","volume":"13","author":"Solym\u00e1r","year":"2018","journal-title":"PLoS One."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0160","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.2147\/CMAR.S200059","article-title":"The Beneficial Effects of Metformin on Cancer Prevention and Therapy: A Comprehensive Review of Recent Advances","volume":"11","author":"Saraei","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0165","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2017-00042","article-title":"Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management","volume":"102","author":"Paschou","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.archger.2018.07.019","article-title":"Association of Metformin Use With Vitamin B12 Deficiency in the Institutionalized Elderly","volume":"79","author":"Wong","year":"2018","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0175","series-title":"American College of Radiology Manual on Contrast Media","year":"2020"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0180","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jama.2019.13772","article-title":"CAROLINA Investigators, Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial","volume":"322","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0185","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S2213-8587(17)30317-0","volume":"5","author":"Vaccaro","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0190","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/dme.12232","article-title":"Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis","volume":"30","author":"Phung","year":"2013","journal-title":"Diabet. Med."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/1753-0407.13035","article-title":"A Lion in the Room: Has the CAROLINA Trial Definitely Resolved the Issue of the Cardiovascular Safety of Sulfonylureas?","volume":"12","author":"Koufakis","year":"2020","journal-title":"J. Diabetes"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0200","doi-asserted-by":"crossref","first-page":"i3625","DOI":"10.1136\/bmj.i3625","article-title":"Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study","volume":"2354","author":"van Dalem","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0205","article-title":"Hyogo Diabetes Hypoglycemia Cognition Complications (HDHCC) study group, Relationships Between Time in Range, Glycemic Variability Including Hypoglycemia, and Types of Diabetes Therapy in Japanese Patients With Type 2 Diabetes Mellitus: HDHCC Study","author":"Kuroda","year":"2020","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40266-015-0254-0","article-title":"Sulfonylurea Use and Risk of Hip Fractures Among Elderly Men and Women With Type 2 Diabetes","volume":"32","author":"Rajpathak","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0215","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1532-5415.1996.tb03729.x","article-title":"Individual Sulfonylureas and Serious Hypoglycemia in Older People","volume":"44","author":"Shorr","year":"1996","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0220","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/dom.14051","article-title":"Association Between Reduced Kidney Function and Incident Hypoglycaemia in People With Diabetes: The Stockholm Creatinine Measurements (SCREAM) Project","volume":"22","author":"Runesson","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0225","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"PROactive Investigators, Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0230","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"IRIS Trial Investigators, Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0235","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14329","article-title":"Oral Antidiabetes Agents for the Management of Inpatient Hyperglycaemia: So Far, Yet So Close","author":"Koufakis","year":"2020","journal-title":"Diabet. Med."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0240","first-page":"914","article-title":"IRIS Trial Investigators, Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial","volume":"102","author":"Viscoli","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s13340-018-0360-4","article-title":"Pioglitazone Use and Risk of Bladder Cancer: A Systematic Literature Review and Meta-Analysis of Observational Studies","volume":"10","author":"Meht\u00e4l\u00e4","year":"2018","journal-title":"Diabetol. Int."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0250","first-page":"381","article-title":"Long-term risk of rosiglitazone on cardiovascular events - a systematic review and meta-analysis","volume":"69","author":"Cheng","year":"2018","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0255","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1503\/cmaj.080486","article-title":"Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis","volume":"180","author":"Loke","year":"2009","journal-title":"CMAJ."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13098-020-00543-1","article-title":"Evaluation of Efficacy and Safety of DPP-4 Inhibitors for Chinese Elderly Patients With Type 2 Diabetes Mellitus","volume":"12","author":"Yu","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0265","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/dom.12102","article-title":"Alogliptin Versus Glipizide Monotherapy in Elderly Type 2 Diabetes Mellitus Patients With Mild Hyperglycaemia: A Prospective, Double-Blind, Randomized, 1-year Study","volume":"15","author":"Rosenstock","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0270","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"SAVOR-TIMI 53 Steering Committee and Investigators, Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0275","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2337\/dc14-2868","article-title":"SAVOR-TIMI 53 Steering Committee and Investigators, Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial","volume":"38","author":"Leiter","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0280","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jcjd.2019.04.003","article-title":"Update on Cardiovascular Safety of Incretin-Based Therapy in Adults With Type 2 Diabetes Mellitus: A Meta-Analysis of Cardiovascular Outcome Trials","volume":"43","author":"Alfayez","year":"2019","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0285","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/dom.13924","article-title":"Incretin-based Glucose-Lowering Medications and the Risk of Acute Pancreatitis and Malignancies: A Meta-Analysis Based on Cardiovascular Outcomes Trials","volume":"22","author":"Abd El Aziz","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0290","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.pcad.2019.08.003","article-title":"Cardiovascular outcome trials of the newer anti-diabetic medications","volume":"62","author":"Acharya","year":"2019","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0295","doi-asserted-by":"crossref","DOI":"10.1111\/jcpt.13107","article-title":"The Use of Sodium-Glucose Co-Transporter 2 Inhibitors in the Inpatient Setting: Is the Risk Worth Taking?","author":"Koufakis","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0300","article-title":"Sodium-glucose co-transporter-2 Inhibitors and the Risk of Diabetic Ketoacidosis in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","author":"Liu","year":"2020","journal-title":"Diabetes Obes. Metab"},{"issue":"2019","key":"10.1016\/j.maturitas.2020.10.005_bib0305","first-page":"70","article-title":"Inhibition of the Sodium-Glucose Co-Transporter 2 in the Elderly: Clinical and Mechanistic Insights Into Safety and Efficacy","volume":"65","author":"Cintra","year":"1992","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0310","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"CANVAS Program Collaborative Group, Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0315","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"CREDENCE Trial Investigators, Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0320","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/dc19-1476","article-title":"Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study","volume":"43","author":"Cahn","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0325","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2337\/db20-28-OR","article-title":"How Early after Treatment Initiation Are the CV Benefits of Empagliflozin Apparent? A Post Hoc Analysis of EMPA-REG OUTCOME","volume":"69","author":"Verma","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0330","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/1932296820932155","article-title":"Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?","volume":"14","author":"Koufakis","year":"2020","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0335","doi-asserted-by":"crossref","first-page":"2S28","DOI":"10.1016\/S1262-3636(17)30070-8","article-title":"GLP-1 Receptor Agonists in NAFLD","volume":"43","author":"Petit","year":"2017","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0340","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2337\/diacare.24.5.964","article-title":"Glucagon-like peptide-1 (7-37) Augments Insulin Release in Elderly Patients With Diabetes","volume":"24","author":"Meneilly","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0345","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/dom.13331","article-title":"Semaglutide as a Therapeutic Option for Elderly Patients With Type 2 Diabetes: Pooled Analysis of the SUSTAIN 1-5 Trials","volume":"20","author":"Warren","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0350","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/dmrr.2588","article-title":"Efficacy and Safety of Lixisenatide in Elderly (\u226565 Years Old) and Very Elderly (\u226575 Years Old) Patients With Type 2 Diabetes: An Analysis From the GetGoal Phase III Programme","volume":"31","author":"Raccah","year":"2015","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0355","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319862691","article-title":"Effects of Glucagon-Like Peptide 1 Receptor Agonists on Comorbidities in Older Patients With Diabetes Mellitus","volume":"10","author":"Onoviran","year":"2019","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0360","first-page":"1664","article-title":"Exenatide Once Weekly Versus Placebo in Parkinson\u2019s Disease: A Randomised, Double-Blind","volume":"390","author":"Athauda","year":"2017","journal-title":"Placebo-Controlled Trial, Lancet"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0365","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JPD-140364","article-title":"Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson\u2019s Disease","volume":"4","author":"Aviles-Olmos","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0370","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jad.2016.09.056","article-title":"Liraglutide Promotes Improvements in Objective Measures of Cognitive Dysfunction in Individuals With Mood Disorders: A Pilot, Open-Label Study","volume":"207","author":"Mansur","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0375","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12020-014-0361-4","article-title":"Risk of Bone Fractures Associated With Glucagon-Like peptide-1 Receptor Agonists\u2019 Treatment: A Meta-Analysis of Randomized Controlled Trials","volume":"48","author":"Su","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0380","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2015-000104","article-title":"A Randomized Controlled Trial Comparing Treatment With Oral Agents and Basal Insulin in Elderly Patients With Type 2 Diabetes in Long-Term Care Facilities","volume":"3","author":"Pasquel","year":"2015","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0385","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1532-5415.2007.01043.x","article-title":"Combination of Oral Antidiabetic Agents With Basal Insulin Versus Premixed Insulin Alone in Randomized Elderly Patients With Type 2 Diabetes Mellitus","volume":"55","author":"Janka","year":"2007","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0390","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.clinthera.2004.12.015","article-title":"Lispro Mixture-Glargine Study Group, Combined therapy with insulin lispro Mix 75\/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy","volume":"26","author":"Malone","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0395","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s40266-013-0128-2","article-title":"Elderly Patients With Diabetes Experience a Lower Rate of Nocturnal Hypoglycaemia With Insulin Degludec Than With Insulin Glargine: A Meta-Analysis of Phase IIIa Trials","volume":"30","author":"Sorli","year":"2013","journal-title":"Drugs Aging"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0400","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/1753-0407.12096","article-title":"Role of premixed insulin analogues in the treatment of patients with type 2 diabetes mellitus: a narrative review","volume":"6","author":"Elizarova","year":"2014","journal-title":"J. Diabetes"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0405","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2337\/diacare.21.2.231","article-title":"Hospitalization and mortality of diabetes in older adults. A 3-year prospective study","volume":"21","author":"Rosenthal","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0410","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.2337\/dc20-S015","article-title":"15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0415","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.2337\/dc20-S012","article-title":"12. Older Adults: Standards of Medical Care in Diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.maturitas.2020.10.005_bib0420","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","article-title":"Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial","volume":"5","author":"Pasquel","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0425","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11892-019-1184-8","article-title":"Debate on Insulin vs Noninsulin Use in the Hospital Setting-Is It Time to Revise the Guidelines for the Management of Inpatient Diabetes?","volume":"19","author":"Pasquel","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0430","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4093\/dmj.2017.0065","article-title":"Higher Prevalence and Progression Rate of Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus","volume":"42","author":"Kim","year":"2018","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.maturitas.2020.10.005_bib0435","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11606-013-2595-x","article-title":"Pitfalls in Hemoglobin A1c Measurement: When Results May Be Misleading","volume":"29","author":"Radin","year":"2014","journal-title":"J. Gen. Intern. Med"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512220303996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512220303996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:18:01Z","timestamp":1759915081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512220303996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":87,"alternative-id":["S0378512220303996"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2020.10.005","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes management in people aged over seventy-five years: targets and treatment strategies","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}